arrow_back Back to App

Stomach Cancer Act: Reviewing Screening and Early Detection Strategies

This Act requires the National Cancer Institute (NCI) to conduct a comprehensive review of stomach cancer incidence, prevention, and screening practices across the United States. The goal is to identify gaps in current awareness and detection methods, particularly for high-risk populations. Citizens stand to benefit from future improvements in health education and the potential establishment of routine, life-saving screening guidelines based on the NCI's findings.
Key points
NCI must study the current incidence of stomach cancer, risk factors, and the optimal age for testing and treating H. pylori infection.
The review will assess the availability and effectiveness of current screening methods, such as endoscopy, for high-risk groups.
Within 18 months, NCI must report to Congress with recommendations for defining high-risk populations and establishing routine screening guidelines.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_9304
Sponsor: Rep. Caraveo, Yadira [D-CO-8]
Process start date: 2024-08-06
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Stomach Cancer Prevention and Early Detection Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_9304.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-08-06.

What are the main provisions?

Key points include:

  • NCI must study the current incidence of stomach cancer, risk factors, and the optimal age for testing and treating H. pylori infection.
  • The review will assess the availability and effectiveness of current screening methods, such as endoscopy, for high-risk groups.
  • Within 18 months, NCI must report to Congress with recommendations for defining high-risk populations and establishing routine screening guidelines.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Caraveo, Yadira [D-CO-8].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health